AEGR | | Aegerion Pharmaceuticals, Inc. | Harshbarger Benjamin | General Counsel | Apr 01, 2016 | Option Exercise | $3.55 | 273 | 969 | 594 | Sep 20, 2016, 04:03 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Harshbarger Benjamin | General Counsel | Sep 17, 2016 | Option Exercise | $1.78 | 532 | 947 | 1,704 | Sep 20, 2016, 04:03 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | KOTLER KEVIN | 10% Owner | Sep 13, 2016 | Buy | $1.75 | 75,000 | 131,250 | 4,361,291 | Sep 14, 2016, 04:16 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Broadfin Capital, LLC | 10% Owner | Sep 09, 2016 | Buy | $1.60 | 100,000 | 159,500 | 4,110,291 | Sep 12, 2016, 06:44 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | KOTLER KEVIN | 10% Owner | Sep 12, 2016 | Buy | $1.70 | 176,000 | 298,800 | 4,286,291 | Sep 12, 2016, 06:44 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | SMITH SANDFORD D | Director | Jul 27, 2016 | Option Exercise | $1.55 | 777 | 1,204 | 2,890 | Jul 29, 2016, 04:01 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | KOTLER KEVIN | 10% Owner | Mar 17, 2016 | Option Exercise | $7.50 | 2,400 | 18,000 | 3,512,691 | Mar 21, 2016, 04:48 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Broadfin Capital, LLC | 10% Owner | Mar 18, 2016 | Option Exercise | $7.50 | 497,600 | 3,732,000 | 4,010,291 | Mar 21, 2016, 04:48 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | SMITH SANDFORD D | Director | Jan 27, 2016 | Option Exercise | $6.78 | 778 | 5,275 | 1,445 | Jan 29, 2016, 06:05 AM |
AEGR | | Aegerion Pharmaceuticals, Inc. | KOTLER KEVIN | 10% Owner | Nov 11, 2015 | Buy | $10.96 | 40,100 | 439,649 | 4,010,291 | Nov 13, 2015, 03:24 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Fitzpatrick Mark J. | Chief Financial Officer | Aug 19, 2014 | Buy | $30.64 | 1,150 | 35,236 | 9,500 | Aug 20, 2014, 09:36 AM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Beer Marc D | Chief Executive Officer | Jul 31, 2014 | Buy | $33.65 | 10,000 | 336,539 | 79,400 | Jul 31, 2014, 12:30 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Beer Marc D | Chief Executive Officer | Jun 03, 2014 | Buy | $30.12 | 10,000 | 301,200 | 69,400 | Jun 04, 2014, 09:30 AM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Beer Marc D | Chief Executive Officer | May 27, 2014 | Buy | $31.59 | 10,000 | 315,900 | 59,400 | May 27, 2014, 12:57 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Beer Marc D | Chief Executive Officer | May 21, 2014 | Option Exercise | $1.54 | 6,400 | 9,856 | 49,400 | May 22, 2014, 09:39 AM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Beer Marc D | Chief Executive Officer | May 20, 2014 | Buy | $30.53 | 10,000 | 305,300 | 43,000 | May 21, 2014, 09:40 AM |
AEGR | | Aegerion Pharmaceuticals, Inc. | VANLENT ANNE | Director | May 08, 2014 | Buy | $33.78 | 4,000 | 135,110 | 4,000 | May 09, 2014, 09:24 AM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Beer Marc D | Chief Executive Officer | May 08, 2014 | Buy | $35.31 | 30,000 | 1,059,300 | 33,000 | May 08, 2014, 10:20 AM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Fraser Craig | Pres., US/Int. Comm. & Manuf. | Mar 31, 2014 | Sale | $29.60 | 4,500 | 133,219 | 2,250 | Apr 02, 2014, 04:01 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Beer Marc D | Chief Executive Officer | Mar 26, 2014 | Option Exercise | $1.54 | 3,000 | 4,620 | 3,000 | Mar 27, 2014, 05:26 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Sumeray Mark | Chief Medical Officer | Mar 14, 2014 | Sale | $32.17 | 4,000 | 128,690 | 2,000 | Mar 18, 2014, 04:01 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Fitzpatrick Mark J. | Chief Financial Officer | Mar 04, 2014 | Option Exercise | $17.64 | 2,500 | 44,100 | 8,350 | Mar 05, 2014, 06:46 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Sumeray Mark | Chief Medical Officer | Feb 14, 2014 | Sale | $38.25 | 4,000 | 152,990 | 2,000 | Feb 18, 2014, 04:05 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Fraser Craig | Pres., US/Int. Comm. & Manuf. | Feb 11, 2014 | Sale | $40.01 | 4,500 | 180,023 | 2,250 | Feb 12, 2014, 04:01 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Fitzpatrick Mark J. | Chief Financial Officer | Feb 10, 2014 | Sale | $40.12 | 15,000 | 601,843 | 13,350 | Feb 12, 2014, 04:01 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Sumeray Mark | Chief Medical Officer | Jan 16, 2014 | Sale | $35.82 | 4,000 | 143,289 | 2,000 | Jan 21, 2014, 04:01 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Fraser Craig | Pres., US/Int. Comm. & Manuf. | Jan 02, 2014 | Sale | $42.06 | 4,500 | 189,271 | 2,250 | Jan 06, 2014, 04:02 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Sumeray Mark | Chief Medical Officer | Jan 02, 2014 | Sale | $41.97 | 2,000 | 83,944 | 1,000 | Jan 06, 2014, 04:01 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Sumeray Mark | Chief Medical Officer | Dec 16, 2013 | Sale | $39.68 | 4,000 | 158,707 | 2,000 | Dec 17, 2013, 04:06 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Beer Marc D | Chief Executive Officer | Dec 04, 2013 | Option Exercise | $1.54 | 4,380 | 6,745 | 4,380 | Dec 06, 2013, 07:24 AM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Sumeray Mark | Chief Medical Officer | Dec 02, 2013 | Sale | $41.72 | 6,000 | 250,297 | 3,000 | Dec 04, 2013, 05:01 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Fraser Craig | Pres., US/Int. Comm. & Manuf. | Dec 02, 2013 | Sale | $41.71 | 4,500 | 187,695 | 2,250 | Dec 04, 2013, 05:00 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Sumeray Mark | Chief Medical Officer | Nov 15, 2013 | Sale | $44.55 | 4,000 | 178,202 | 2,000 | Nov 19, 2013, 05:00 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Fitzpatrick Mark J. | Chief Financial Officer | Nov 11, 2013 | Sale | $43.44 | 17,850 | 775,403 | 10,500 | Nov 13, 2013, 05:31 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Beer Marc D | Chief Executive Officer | Nov 05, 2013 | Option Exercise | $1.54 | 39,000 | 60,060 | 234,726 | Nov 06, 2013, 05:05 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Carter Martha J. | Chief Regulatory Officer & SVP | Nov 01, 2013 | Sale | $48.83 | 10,000 | 488,250 | 6,500 | Nov 05, 2013, 04:01 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Sumeray Mark | Chief Medical Officer | Nov 01, 2013 | Sale | $48.15 | 7,000 | 337,016 | 3,500 | Nov 05, 2013, 04:00 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Fraser Craig | Pres., US/Int. Comm. & Manuf. | Nov 01, 2013 | Option Exercise | $48.12 | 4,500 | 216,548 | 2,250 | Nov 05, 2013, 04:00 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Beer Marc D | Chief Executive Officer | Oct 30, 2013 | Sale | $44.67 | 80,000 | 3,573,265 | 235,726 | Oct 31, 2013, 08:35 AM |
AEGR | | Aegerion Pharmaceuticals, Inc. | SMITH SANDFORD D | Director | Oct 29, 2013 | Sale | $55.00 | 5,004 | 275,220 | 2,502 | Oct 31, 2013, 08:32 AM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Sumeray Mark | Chief Medical Officer | Oct 15, 2013 | Sale | $46.67 | 4,000 | 186,679 | 2,000 | Oct 16, 2013, 05:04 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Sumeray Mark | Chief Medical Officer | Oct 07, 2013 | Option Exercise | $53.09 | 7,000 | 371,621 | 3,500 | Oct 08, 2013, 05:15 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Fraser Craig | Pres., US/Int. Comm. & Manuf. | Oct 07, 2013 | Sale | $53.08 | 40,000 | 2,123,346 | 20,000 | Oct 08, 2013, 04:58 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Sumeray Mark | Chief Medical Officer | Sep 16, 2013 | Sale | $51.39 | 4,000 | 205,569 | 2,000 | Sep 18, 2013, 04:05 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 10% Owner | Jun 15, 2013 | Option Exercise | $25.00 | 200,000 | 5,000,000 | 3,573,426 | Sep 09, 2013, 06:15 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | EDELMAN JOSEPH | 10% Owner | Sep 05, 2013 | Sale | $89.20 | 750,000 | 66,899,998 | 2,873,426 | Sep 09, 2013, 06:15 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Fitzpatrick Mark J. | Chief Financial Officer | Aug 26, 2013 | Option Exercise | $17.64 | 2,500 | 44,100 | 3,000 | Aug 28, 2013, 04:30 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Scheer David | Director | Aug 21, 2013 | Sale | $84.58 | 20,000 | 1,691,638 | 620,554 | Aug 23, 2013, 08:00 AM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Sumeray Mark | Chief Medical Officer | Aug 16, 2013 | Option Exercise | $50.86 | 4,000 | 203,433 | 2,000 | Aug 20, 2013, 05:06 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Fitzpatrick Mark J. | Chief Financial Officer | Aug 14, 2013 | Sale | $55.54 | 15,000 | 833,116 | 8,000 | Aug 16, 2013, 04:56 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Beer Marc D | Chief Executive Officer | Aug 15, 2013 | Sale | $45.04 | 120,000 | 5,404,609 | 259,061 | Aug 16, 2013, 04:56 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | SMITH SANDFORD D | Director | Aug 09, 2013 | Option Exercise | $51.02 | 18,463 | 941,932 | 10,000 | Aug 13, 2013, 04:00 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | SMITH SANDFORD D | Director | Aug 12, 2013 | Sale | $92.25 | 1,537 | 141,791 | 0 | Aug 13, 2013, 04:00 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Sumeray Mark | Chief Medical Officer | Jul 15, 2013 | Sale | $45.89 | 4,000 | 183,566 | 2,000 | Jul 16, 2013, 05:00 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Sumeray Mark | Chief Medical Officer | Jun 17, 2013 | Sale | $39.14 | 12,000 | 469,680 | 6,000 | Jun 19, 2013, 04:00 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Sumeray Mark | Chief Medical Officer | May 15, 2013 | Sale | $30.17 | 12,000 | 361,990 | 6,000 | May 17, 2013, 04:30 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Sumeray Mark | Chief Medical Officer | Apr 22, 2013 | Sale | $26.88 | 12,000 | 322,511 | 6,000 | Apr 24, 2013, 02:23 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | EDELMAN JOSEPH | 10% Owner | Feb 01, 2013 | Buy | $27.79 | 50,000 | 1,389,400 | 3,373,426 | Feb 05, 2013, 03:54 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Carter Martha J. | Chief Regulatory Officer & SVP | Jan 23, 2013 | Buy | $27.81 | 500 | 13,905 | 1,500 | Jan 24, 2013, 05:12 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | EDELMAN JOSEPH | 10% Owner | Jan 18, 2013 | Buy | $27.62 | 50,000 | 1,381,000 | 3,323,426 | Jan 22, 2013, 01:16 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | EDELMAN JOSEPH | 10% Owner | Jan 17, 2013 | Buy | $26.73 | 50,000 | 1,336,285 | 3,273,426 | Jan 18, 2013, 01:57 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | EDELMAN JOSEPH | 10% Owner | Jan 11, 2013 | Buy | $27.07 | 475,000 | 12,857,220 | 3,223,426 | Jan 15, 2013, 06:07 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 10% Owner | Dec 04, 2012 | Buy | $21.27 | 20,000 | 425,400 | 2,615,293 | Dec 05, 2012, 01:05 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Nov 29, 2012 | Buy | $22.71 | 30,000 | 681,300 | 2,595,293 | Dec 03, 2012, 02:29 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 10% Owner | Nov 07, 2012 | Buy | $21.12 | 30,000 | 633,600 | 2,445,293 | Dec 03, 2012, 10:36 AM |
AEGR | | Aegerion Pharmaceuticals, Inc. | EDELMAN JOSEPH | 10% Owner | Nov 15, 2012 | Buy | $19.50 | 10,000 | 195,000 | 2,455,293 | Dec 03, 2012, 10:36 AM |
AEGR | | Aegerion Pharmaceuticals, Inc. | PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 10% Owner | Nov 20, 2012 | Buy | $21.01 | 20,000 | 420,200 | 2,475,293 | Dec 03, 2012, 10:36 AM |
AEGR | | Aegerion Pharmaceuticals, Inc. | EDELMAN JOSEPH | 10% Owner | Nov 21, 2012 | Buy | $20.75 | 20,000 | 415,000 | 2,495,293 | Dec 03, 2012, 10:36 AM |
AEGR | | Aegerion Pharmaceuticals, Inc. | PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 10% Owner | Nov 28, 2012 | Buy | $21.76 | 70,000 | 1,523,200 | 2,565,293 | Dec 03, 2012, 10:36 AM |
AEGR | | Aegerion Pharmaceuticals, Inc. | PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 10% Owner | Oct 19, 2012 | Option Exercise | $17.50 | 247,500 | 4,331,250 | 2,347,233 | Dec 03, 2012, 10:34 AM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Kiley Alison | 10% Owner | Oct 15, 2012 | Sale | $17.54 | 55,626 | 975,680 | 2,408,426 | Oct 17, 2012, 06:35 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | CHAMPSI FARAH | 10% Owner | Oct 15, 2012 | Sale | $17.54 | 5,107 | 89,577 | 161,742 | Oct 17, 2012, 06:35 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG | 10% Owner | Oct 16, 2012 | Sale | $18.67 | 128,229 | 2,394,035 | 2,280,197 | Oct 17, 2012, 06:35 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | ALTA BIOPHARMA MANAGEMENT III LLC | 10% Owner | Oct 16, 2012 | Sale | $18.67 | 11,771 | 219,765 | 153,131 | Oct 17, 2012, 06:35 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Carter Martha J. | Chief Regulatory Officer | Mar 30, 2012 | Buy | $14.03 | 1,000 | 14,030 | 1,000 | Apr 02, 2012, 01:10 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Beer Marc D | Chief Executive Officer | Mar 29, 2012 | Buy | $13.74 | 1,000 | 13,735 | 199,061 | Mar 30, 2012, 09:19 AM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Fitzpatrick Mark J. | Chief Financial Officer | Mar 23, 2012 | Buy | $14.15 | 500 | 7,076 | 500 | Mar 26, 2012, 09:27 AM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Beer Marc D | Chief Executive Officer | Mar 22, 2012 | Buy | $13.96 | 1,000 | 13,964 | 198,061 | Mar 23, 2012, 10:02 AM |
AEGR | | Aegerion Pharmaceuticals, Inc. | ADVENT INTERNATIONAL CORP/MA | Member of Group > 10% | Mar 09, 2012 | Sale | $15.87 | 100,000 | 1,586,830 | 2,457,879 | Mar 14, 2012, 03:29 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | ADVENT INTERNATIONAL LLC | Member of Group > 10% | Mar 09, 2012 | Sale | $15.87 | 98,897 | 1,569,327 | 2,430,765 | Mar 14, 2012, 03:19 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | ADVENT HEALTHCARE & LIFE SCIENCES III LIMITED PARTNERSHIP | Member of Group > 10% | Mar 09, 2012 | Sale | $15.87 | 40,077 | 635,954 | 985,052 | Mar 14, 2012, 03:16 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Advent Healthcare & Life Sciences III-A Limited Partnership | Member of Group > 10% | Mar 09, 2012 | Sale | $15.87 | 58,820 | 933,373 | 1,445,713 | Mar 14, 2012, 03:09 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | AHLS III GP LIMITED PARTNERSHIP | Member of Group > 10% | Mar 09, 2012 | Sale | $15.87 | 98,897 | 1,569,327 | 2,430,765 | Mar 14, 2012, 03:08 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Advent Partners HLS III Limited Partnership | Member of Group > 10% | Mar 09, 2012 | Sale | $15.87 | 1,103 | 17,503 | 27,114 | Mar 14, 2012, 03:04 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Yucca Partners L.P. Jersey Branch | 10% Owner | Jan 30, 2012 | Sale | $17.08 | 50,000 | 854,000 | 2,081,827 | Feb 01, 2012, 08:18 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | AHLS III GP LIMITED PARTNERSHIP | Member of Group > 10% | Jan 27, 2012 | Sale | $17.17 | 49,448 | 848,800 | 2,554,386 | Jan 31, 2012, 06:02 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | AHLS III GP LIMITED PARTNERSHIP | Member of Group > 10% | Jan 30, 2012 | Sale | $17.06 | 2,670 | 45,563 | 2,551,716 | Jan 31, 2012, 06:02 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | AHLS III GP LIMITED PARTNERSHIP | Member of Group > 10% | Jan 31, 2012 | Sale | $17.10 | 22,054 | 377,156 | 2,529,662 | Jan 31, 2012, 06:02 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Advent Partners HLS III Limited Partnership | Member of Group > 10% | Jan 30, 2012 | Sale | $17.06 | 30 | 512 | 28,463 | Jan 31, 2012, 06:01 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Advent Partners HLS III Limited Partnership | Member of Group > 10% | Jan 31, 2012 | Sale | $17.10 | 246 | 4,207 | 28,217 | Jan 31, 2012, 06:01 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Advent Partners HLS III Limited Partnership | Member of Group > 10% | Jan 27, 2012 | Sale | $17.17 | 552 | 9,475 | 28,493 | Jan 31, 2012, 06:01 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | ADVENT INTERNATIONAL LLC | Member of Group > 10% | Jan 27, 2012 | Sale | $17.17 | 49,448 | 848,800 | 2,554,386 | Jan 31, 2012, 06:00 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | ADVENT INTERNATIONAL LLC | Member of Group > 10% | Jan 30, 2012 | Sale | $17.06 | 2,670 | 45,563 | 2,551,716 | Jan 31, 2012, 06:00 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | ADVENT INTERNATIONAL LLC | Member of Group > 10% | Jan 31, 2012 | Sale | $17.10 | 22,054 | 377,156 | 2,529,662 | Jan 31, 2012, 06:00 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | ADVENT INTERNATIONAL CORP/MA | Member of Group > 10% | Jan 30, 2012 | Sale | $17.06 | 2,700 | 46,075 | 2,580,179 | Jan 31, 2012, 05:59 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | ADVENT INTERNATIONAL CORP/MA | Member of Group > 10% | Jan 31, 2012 | Sale | $17.10 | 22,300 | 381,363 | 2,557,879 | Jan 31, 2012, 05:59 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | ADVENT INTERNATIONAL CORP/MA | Member of Group > 10% | Jan 27, 2012 | Sale | $17.17 | 50,000 | 858,275 | 2,582,879 | Jan 31, 2012, 05:59 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Advent Healthcare & Life Sciences III-A Limited Partnership | Member of Group > 10% | Jan 27, 2012 | Sale | $17.17 | 29,409 | 504,820 | 1,519,238 | Jan 31, 2012, 05:55 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Advent Healthcare & Life Sciences III-A Limited Partnership | Member of Group > 10% | Jan 30, 2012 | Sale | $17.06 | 1,588 | 27,099 | 1,517,650 | Jan 31, 2012, 05:55 PM |
AEGR | | Aegerion Pharmaceuticals, Inc. | Advent Healthcare & Life Sciences III-A Limited Partnership | Member of Group > 10% | Jan 31, 2012 | Sale | $17.10 | 13,117 | 224,320 | 1,504,533 | Jan 31, 2012, 05:55 PM |